Effects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment
FAME3
Effects of t-DCS Combined With Concurrent Cognitive Training on Apathy in Elderly Subjects With Minor Neurocognitive Impairment
1 other identifier
interventional
27
1 country
1
Brief Summary
Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique using a low intensity electric current to modify cortical excitability. Apathy is a pervasive neuropsychiatric symptom characterized by a reduction in goal-directed behavior and activity that persists over time and causes identifiable functional impairment. The aim of this study is to evaluate the effects of repeated sessions of tDCS combined with simultaneous cognitive training on apathy in older people with minor neurocognitive disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2021
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedStudy Start
First participant enrolled
April 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2026
ExpectedNovember 26, 2025
November 1, 2025
3 years
December 21, 2021
November 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Apathy Inventory (Robert et al., 2002), clinician version
The Apathy Inventory scored from 0 (No problem) to 4 (major problem) the 3 dimensions of apathy: the emotional blunting, the loss of initiative and the loss of interest. A higher total score indicates a greater severity.
Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)
Secondary Outcomes (12)
Assessment of neuropsychiatric symptoms
Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)
Assessment of the global cognitive functioning
Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)
Assessment of cognitive functions with FAB
Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)
Assessment of episodic memory
Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)
Assessment of attention and mental flexibilty
Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)
- +7 more secondary outcomes
Study Arms (2)
tDCS combined with simultaneous cognitive training
EXPERIMENTALcognitive training with a combined sham tDCS
SHAM COMPARATORInterventions
The control group will follow cognitive training with a combined sham tDCS. Intervention will last for 4-week with 3 sessions per week (12 sessions).
The intervention group will follow sessions of tDCS combined with a simultaneous cognitive training on tablet
Eligibility Criteria
You may qualify if:
- Age ≥ 65 years
- Subject consulting in one of the investigating centers
- Clinical diagnosis of Minor Neurocognitive Disorder according to DSM 5 criteria (APA, 2013)
- Apathetic syndrome defined according to the Diagnostic Criteria for Apathy (Miller \& al., 2021)
- Subject who can read and write French
- Subjects who are beneficiaries of a social security plan
- Signature of free and informed consent
You may not qualify if:
- Current clinical diagnosis of a depressive episode characterized by DSM 5 criteria (APA, 2013)
- Known diagnosis of schizophrenia, bipolar disorder, substance abuse or dependence
- Significant sensory or motor impairment
- Subject under guardianship, conservatorship, or conservatorship
- Active smoking or smoking cessation of less than one year
- Contraindications to the practice of tDCS: history of intracranial hypertension, neurosurgery, metallic implant at the cephalic level, pacemaker
- Unbalanced epilepsy
- Severe somatic disease not stabilized
- Previous use of tDCS (problem of maintaining the integrity of the blinding procedure)
- Scalp skin disease
- Concurrent participation in another drug research study or any other study that may interfere with study results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Memoire Ressources et Recherche, CHU de Nice
Nice, 06000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric ETTORE, MD
Nice University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2021
First Posted
February 10, 2022
Study Start
April 5, 2022
Primary Completion
April 4, 2025
Study Completion (Estimated)
June 10, 2026
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share